A Study of Golimumab in Participants With Active Psoriatic Arthritis
Status:
Completed
Trial end date:
2017-03-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of intravenously (administration of a
fluid into the vein) administered golimumab 2 milligram per kilogram (mg/kg) in participants
with active psoriatic arthritis (a chronic inflammatory arthritis that is associated with
psoriasis).